End-of-day quote
Other stock markets
|
||
- | - |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Research Service
86.4
%
| 8,733 | 30.3 % | 83,399 | 86.4 % | +855.03% |
Merchandise
13.4
%
| 18,733 | 65.0 % | 12,949 | 13.4 % | -30.87% |
Transgenic Animal and Plant Development Product
0.2
%
| 1,341 | 4.7 % | 174 | 0.2 % | -87.01% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
86.4
%
| 9,092 | 31.6 % | 83,385 | 86.4 % | +817.15% |
South Korea
13.6
%
| 19,715 | 68.4 % | 13,138 | 13.6 % | -33.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sun-Jae Park
CEO | Chief Executive Officer | 69 | 08-05-12 |
Sang-Woo Kang
DFI | Director of Finance/CFO | 58 | 20-05-31 |
Gyu-Wan Kim
CTO | Chief Tech/Sci/R&D Officer | 58 | - |
Seung-Ju Lee
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Min-Seok Lee
IRC | Investor Relations Contact | 61 | - |
Byung-Kyu Lee
AUD | Comptroller/Controller/Auditor | 58 | 21-03-28 |
Hye-Sin Jung
PRN | Corporate Officer/Principal | 67 | 08-05-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sun-Jae Park
CEO | Chief Executive Officer | 69 | 08-05-12 |
Jong-In Choi
BRD | Director/Board Member | 59 | 21-03-28 |
In-Young Go
BRD | Director/Board Member | 68 | 21-03-28 |
Hye-Sin Jung
PRN | Corporate Officer/Principal | 67 | 08-05-12 |
Sang-Woo Kang
DFI | Director of Finance/CFO | 58 | 20-05-31 |
Yang-Woo Kim
BRD | Director/Board Member | 55 | 21-03-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2 | 0 | 2 ( 100.00 %) | 68.48 % |
Stock B | 1 | 53,011,828 | 36,304,769 ( 68.48 %) | 23,706 ( 0.0447 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ALTEOGEN INC. 0.04% | 23,706 | 0.04% | 3,476,000 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-17.49% | 31.47B | |
+54.44% | 25.24B | |
-13.13% | 15.82B | |
-9.12% | 11.96B | |
-15.45% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- A196170 Stock
- Stock
- Company Alteogen Inc